danazol,momelotinib
sierra oncology
['momelotinib', '#mpn', 'momentum', 'mpnsm', '#myelof']
congress #asco22 | reports on the momentum phase iii of momelotinib+danazol in #myelofibrosis (n=130). the primary endpoints were met. mfsaf tss response rate at 24 weeks was 32 (mmb) &amp; 6 (dan). the spleen rr was 30 (mmb) &amp; 2 (dan) at 35% reduction #mpnsm #mpn 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm